Altimmune (ALT) Preferred Shares Repurchased (2018)

Altimmune (ALT) reported Preferred Shares Repurchased of $1.0 for Q4 2018, down 100.0% quarter-over-quarter from $22240.0 in Q3 2018.

Altimmune (ALT) Preferred Shares Repurchased (2018) Analysis & Trends

Altimmune (ALT) has 1 years of Preferred Shares Repurchased data on file, last reported at $1.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Repurchased (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Altimmune	336.67 Mn	336.67 Mn	-	-

Download Data